Vera Therapeutics Inc Class A (VERA)
EBITDA Growth
-44.21%
Quarterly · Period ending:
VERA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-44.21%period ending
Latest reported-44.21%period ending
VERA Quarterly EBITDA YoY % (-99.79% → -44.21%)
Year-over-year change
High-resolution chart · PNG
VERA ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -44.2123% | |
| -139.0128% | |
| -114.6055% | |
| -75.0627% | |
| -134.5364% | |
| -88.2302% | |
| -52.7852% | |
| -133.2133% | |
| -69.6706% | |
| 10.8919% | |
| 14.5746% | |
| 21.9183% | |
| -27.2054% | |
| -75.1445% | |
| -89.3236% | |
| -224.8411% | |
| -334.7505% | |
| -262.4279% | |
| 58.9562% | |
| -102.8472% | |
| 1.2248% | |
| -99.7865% |